Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.2. Drivers
4.2.1. Rising research & investment activities related to wound care

4.3. Restraints
4.3.1. The high cost associated with the wound care products
4.4. Opportunities
4.5. Impact Analysis
5. Industry Factors
5.1. Porter’s Five Forces
5.2. Regulator Analysis
5.3. Supply Chain Analysis
5.4. Reimbursement Analysis
5.5. PEST Analysis
5.6. Pricing Analysis
6. By Product
6.1. Introduction
6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
6.1.2. Market Attractiveness Index, By Product
6.2. Exudate Management*
6.2.1. Introduction
6.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
6.2.3. Hydrogel
6.2.4. Foam
6.2.5. Silicone Dressing
6.2.5.1. Silicone Lite Foam Dressing
6.2.5.2. Silicone absorbent dressings
6.2.5.3. Silicone gel sheets
6.2.6. Hydrocolloids
6.2.7. Alginate
6.2.8. Super Absorbent
6.3. Infection Management
6.3.1. Silver Wound Dressing
6.3.2. Collagen Dressing
6.3.3. Non-Silver Dressing
6.4. Skin Substitutes
6.4.1. Xenograft
6.4.2. Allograft
6.4.3. Placenta/Amniotic Tissue
6.4.4. Bioengineered skin/synthetic Substitutes
6.5. Therapy Devices
6.5.1. Negative Pressure Wound Therapies (NPWT Devices)
6.5.1.1. Conventional Negative Pressure Wound Therapy (NPWT)
6.5.1.1.1. Pumps
6.5.1.1.2. Canisters
6.5.1.1.3. Dressing Kits
6.5.1.2. Single-Use Negative Pressure Wound Therapy (NPWT)
6.5.2. Hyperbaric Oxygen Therapy
6.5.3. Ultrasonic Mist and Electrical Stimulation Devices
6.6. Compression Bandage
6.6.1. Full Compression – 2 layers
6.6.2. Others
6.7. Hemostatic Dressing
6.8. Nanofibre Dressing
7. By Wound Type
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
7.1.2. Market Attractiveness Index, By Wound Type
7.2. Chronic Wounds*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.2.3. Pressure Ulcer (PU)
7.2.4. Venous Leg Ulcer (VLU)
7.2.5. Diabetic Foot Ulcer (DFU)
7.3. Acute Wounds
8. By Region
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
8.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
8.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.2.5.1. The U.S.
8.2.5.2. Canada
8.2.5.3. Mexico
8.3. South America
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
8.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
8.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.3.5.1. Brazil
8.3.5.2. Argentina
8.3.5.3. Rest of South America
8.4. Europe
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
8.4.5.1. Germany
8.4.5.2. The U.K.
8.4.5.3. France
8.4.5.4. Spain
8.4.5.5. Italy
8.4.5.6. Rest of Europe
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
8.5.4.1. China
8.5.4.2. India
8.5.4.3. Japan
8.5.4.4. Australia
8.5.4.5. Rest of Asia-Pacific
8.6. Middle East & Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Wound Type
9. Competitive Landscape
9.1. Competitive Scenario
9.2. Market Positioning/Share Analysis
9.3. Mergers and Acquisitions Analysis
10. Company Profiles
10.1. 3M Healthcare
10.1.1. Company Overview
10.1.2. Product Portfolio and Description
10.1.3. Key Highlights
10.1.4. Financial Overview
10.2. Urgo Medical
10.3. B. Braun Medical
10.4. Coloplast A/s
10.5. ConvaTec Inc
10.6. Derma Sciences, Inc
10.7. Paul Hartmann AG
10.8. Smith & Nephew
10.9. Medline Industries, Inc.
10.10. Acelity
10.11. Molnlycke Healthcare
10.12. Oranogenesis
LIST NOT EXHAUSTIVE
11. Global Advanced Wound Care Market – DataM
11.1. Appendix
11.2. About Us
11.3. Contact Us